MarketPeel
Insider Trading Intelligence
RK

Rachel K. King

FULC
DIRECTOR · FULCRUM THERAPEUTICS, INC. · CIK 0001589712
FILING MIX · LIFETIME76%/24%
BUYS
25
SELLS
8
TOTAL VALUE
$564.9K
COMPANIES
2
ACTIVE SINCE
Jun 2020
HOLDINGS NOW
32,000
AVG SELL PX
$9.02
TRADE KIND
SHOWING 33 / 33
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
2 backtested trades · 8 horizons · 1 pending
Forward-return performance of every backtestable P/S trade by Rachel K. King, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d2+100.00%+0.83%+0.08%+0.75%+0.75%
14d2+100.00%+5.70%+0.56%+5.14%+5.14%
30d2+100.00%+8.58%-1.07%+9.65%+9.65%
60d2+100.00%+18.40%+2.15%+16.25%+16.25%
90d2+100.00%+27.36%+0.00%+27.36%+27.36%
180d2+100.00%-0.42%+7.34%-7.76%-7.76%
1y2+50.00%-43.39%+4.80%-48.19%-48.19%
2y2(1 pending)+0.00%-94.97%+4.98%-99.95%-99.95%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
FULC · 32,000 shares · as of Jun 30, 2026
015,00030,00045,00060,00020252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 25 buys / 8 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
FULC
FULCRUM THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
32,00032,000Jun 30, 2026Jul 2, 2026View →
NVAX
NOVAVAX INC
PURCHASE
18,88044,070Jun 20, 2026Jun 23, 2026View →
NVAX
NOVAVAX INC
SALE
18,8800Jun 20, 2026Jun 23, 2026View →
NVAX
NOVAVAX INC
PURCHASEGRANT
Stock grant
21,27021,270Jun 18, 2026Jun 23, 2026View →
NVAX
NOVAVAX INC
PURCHASEGRANT
Stock grant
14,18014,180Jun 18, 2026Jun 23, 2026View →
FULC
FULCRUM THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
36,00036,000Jun 26, 2025Jun 30, 2025View →
NVAX
NOVAVAX INC
PURCHASEGRANT
Stock grant
28,326$6.42$181.9K28,326Jun 20, 2025Jun 24, 2025View →
NVAX
NOVAVAX INC
PURCHASEGRANT
Stock grant
18,88418,884Jun 20, 2025Jun 24, 2025View →
NVAX
NOVAVAX INC
SALE
10,4200Jun 12, 2025Jun 13, 2025View →
NVAX
NOVAVAX INC
PURCHASE
10,42025,190Jun 12, 2025Jun 13, 2025View →
NVAX
NOVAVAX INC
SALE
4,150$9.02$37.4K14,770Dec 13, 2024Dec 16, 2024View →
FULC
FULCRUM THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
60,00060,000Nov 12, 2024Nov 14, 2024View →
NVAX
NOVAVAX INC
PURCHASEGRANT
Stock grant
15,630$15.86$247.9K15,630Jun 12, 2024Jun 14, 2024View →
NVAX
NOVAVAX INC
PURCHASEGRANT
Stock grant
10,42010,420Jun 12, 2024Jun 14, 2024View →
NVAX
NOVAVAX INC
SALE
6,6700Jun 12, 2024Jun 14, 2024View →
NVAX
NOVAVAX INC
PURCHASE
6,67018,920Jun 12, 2024Jun 14, 2024View →
NVAX
NOVAVAX INC
PURCHASEGRANT
Stock grant
6,6706,670Jun 12, 2023Jun 13, 2023View →
NVAX
NOVAVAX INC
PURCHASEGRANT
Stock grant
7,7107,710Jun 12, 2023Jun 13, 2023View →
NVAX
NOVAVAX INC
PURCHASE
3,10010,050Jun 10, 2023Jun 13, 2023View →
NVAX
NOVAVAX INC
SALE
3,1000Jun 10, 2023Jun 13, 2023View →
NVAX
NOVAVAX INC
PURCHASE
7006,950Jun 17, 2022Jun 21, 2022View →
NVAX
NOVAVAX INC
SALE
7000Jun 17, 2022Jun 21, 2022View →
NVAX
NOVAVAX INC
PURCHASEGRANT
Stock grant
4,6004,600Jun 10, 2022Jun 14, 2022View →
NVAX
NOVAVAX INC
PURCHASEGRANT
Stock grant
3,1003,100Jun 10, 2022Jun 14, 2022View →
NVAX
NOVAVAX INC
SALE
3,4503,450Jun 25, 2021Aug 20, 2021View →
NVAX
NOVAVAX INC
PURCHASE
3,4506,250Jun 25, 2021Aug 20, 2021View →
NVAX
NOVAVAX INC
SALE
6,9000Jun 25, 2021Jun 29, 2021View →
NVAX
NOVAVAX INC
PURCHASE
6,9009,700Jun 25, 2021Jun 29, 2021View →
NVAX
NOVAVAX INC
PURCHASEGRANT
Stock grant
700700Jun 17, 2021Jun 22, 2021View →
NVAX
NOVAVAX INC
PURCHASEGRANT
Stock grant
1,3001,300Jun 17, 2021Jun 22, 2021View →
NVAX
NOVAVAX INC
PURCHASE
700$139.64$97.7K2,800May 19, 2021May 21, 2021View →
NVAX
NOVAVAX INC
PURCHASEGRANT
Stock grant
6,9006,900Jun 25, 2020Jun 26, 2020View →
NVAX
NOVAVAX INC
PURCHASEGRANT
Stock grant
3,4503,450Jun 25, 2020Jun 26, 2020View →
Other insiders · FULC
Loading peer insiders…
About this filer
CIK 0001589712
ROLE
Director
PRIMARY
FULC
COMPANIES
2
ACTIVE SINCE
Jun 2020
MARKETPEEL · /INSIDER/0001589712DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback